Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapy

Elham Shirvani‐Dastgerdi(Princeton University), Frank Tacke(Charité - Universitätsmedizin Berlin), David Tabernero(Universitat Autònoma de Barcelona), Eray Yagmur, Benjamin Y. Winer(Memorial Sloan Kettering Cancer Center), Yibin Kang(Rutgers, The State University of New Jersey), Francisco Rodríguez‐Frias(Universitat Autònoma de Barcelona), Toni Celià-Terrassa(Princeton University), Josep Gregori(Roche (Spain)), Tom Luedde(Düsseldorf University Hospital), Alexander Ploß(Rockefeller University), Christian Trautwein(TUM Klinikum)
Journal of Hepatology
April 7, 2017
Cited by 62


Related Papers